A Novel Metric to Assess the Clinical Utility of a Drug in the Presence of Efficacy and Dropout Information

The fact that there are high dropout rates in clinical trials of antipsychotic medications raises critical questions regarding the most appropriate method of designing new trials, analyzing efficacy data, and evaluating the clinical utility (CU) of novel treatments. In this article, we consider the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical pharmacology and therapeutics 2012-02, Vol.91 (2), p.215-219
Hauptverfasser:	Goyal, N, Gomeni, R
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic Agents - therapeutic use Biological and medical sciences Clinical Trials as Topic - methods Clinical Trials as Topic - statistics & numerical data Drug Discovery - methods Drug Discovery - statistics & numerical data Humans Medical sciences Models, Statistical Patient Dropouts - statistics & numerical data Pharmacology. Drug treatments Psychiatric Status Rating Scales - statistics & numerical data Schizophrenia - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!